Answer
Yes, mirvetuximab soravtansine can cause severe, life-threatening or fatal interstitial lung disease, including pneumonitis.
Sources for this answer
- ELAHERE 5 mg/mL concentrate for solution for infusionAbbVie Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 2Document updated
Sources checked